Skip to main content

Advertisement

Log in

Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer

  • RESEARCH ARTICLE
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

There are controversial about the application of cancer-directed surgery (CDS) in patients with liver metastases from gastric cancer, with improved responses to chemotherapy and targeted treatments, the role of CDS in metastatic gastric cancer to the liver needs to be revisited. This study aimed to evaluate the effect of CDS on patients with liver metastases from gastric cancer. Data for patients with liver metastases from gastric cancer were extracted from the population-based Surveillance, Epidemiology, and End Results (SEER) database. A total of 958 individuals were enrolled, 285 in the CDS group and 673 in the non-cancer guided surgery (Non-CDS) group. Following propensity score matching (PSM) analysis at 1:1 in the two groups,285 were included in the survival analysis for each group. Kaplan–Meier values and Cox proportional risk models were used to estimate the effect of CDS on patients' prognoses. Compared with the Non-CDS group, the CDS group significantly prolonged the median overall survival from 4 months (95% confidence interval [CI] 3–5) to 11 months (95% CI 8–12), p value < 0.001. Overall survival (OS) at 1 year was higher in the CDS group than in the Non-CDS group, at 44% (95 CI 38–50) and 25% (95 CI 20–30), respectively. OS at 3 years was also higher in the CDS group than in the Non-CDS group, at 24% (95 CI 19–29) and 6% (95 CI 3–9), respectively. Multivariate analysis showed that Non-CDS (hazard ratio[HR] = 2.26, 95% CI 1.88–2.72, p value < 0.001) was an adverse independent prognostic factor for patients. This study concludes that CDS prolonged survival in patients with gastric cancer with liver metastases. Due to the lack of information on the quality of life, biomarkers, targeted therapies, and immunotherapy in the SEER database, the observed improved survival rates following CDS of hepatic metastasis from gastric cancer requires prospective studies that take these factors into account to properly address the survival advantages and impact on quality of life of such a method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data sets generated during and/or analyzed during the current study are available from SEER.

References

  1. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534–42. https://doi.org/10.1016/j.cgh.2019.07.045.

    Article  PubMed  Google Scholar 

  2. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21:4012. https://doi.org/10.3390/ijms21114012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28:1187–203. https://doi.org/10.3748/wjg.v28.i12.1187.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39:1179–203. https://doi.org/10.1007/s10555-020-09925-3.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (London, England). 2020;396:635–48. https://doi.org/10.1016/S0140-6736(20)31288-5.

    Article  CAS  PubMed  Google Scholar 

  6. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1–21. https://doi.org/10.1007/s10120-020-01042-y.

    Article  Google Scholar 

  7. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2022;20:167–92. https://doi.org/10.6004/jnccn.2022.0008.

    Article  CAS  PubMed  Google Scholar 

  8. Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:1005–20. https://doi.org/10.1016/j.annonc.2022.07.004.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang KC, Wang PP, Chen L. Surgical teratment for gastric cancer patients with liver metastasis. Zhonghua Zhong Liu Za Zhi [Chin J Oncol]. 2019;41:183–6. https://doi.org/10.3760/cma.j.issn.0253-3766.2019.03.005.

    Article  CAS  PubMed  Google Scholar 

  10. Li S-C, Lee C-H, Hung C-L, Wu J-C, Chen J-H. Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: a population-based study. PLoS ONE. 2017;12:e0182255. https://doi.org/10.1371/journal.pone.0182255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Aurello P, Minervini A, Pace M, D’Angelo F, Nigri G, Antolino L, et al. The role of surgery in the treatment of metachronous liver metastasis from gastric cancer: a systematic review. Anticancer Res. 2022;42:25–33. https://doi.org/10.21873/anticanres.15453.

    Article  PubMed  Google Scholar 

  12. Picado O, Dygert L, Macedo FI, Franceschi D, Sleeman D, Livingstone AS, et al. The role of surgical resection for stage IV gastric cancer with synchronous hepatic metastasis. J Surg Res. 2018;232:422–9. https://doi.org/10.1016/j.jss.2018.06.067.

    Article  PubMed  Google Scholar 

  13. Xiao Y, Zhang B, Wu Y. Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study. Ir J Med Sci. 2019;188:415–24. https://doi.org/10.1007/s11845-018-1864-4.

    Article  CAS  PubMed  Google Scholar 

  14. Arigami T, Matsushita D, Okubo K, Kawasaki Y, Iino S, Sasaki K, et al. Indication and prognostic significance of conversion surgery in patients with liver metastasis from gastric cancer. Oncology. 2020;98:273–9. https://doi.org/10.1159/000505555.

    Article  CAS  PubMed  Google Scholar 

  15. Zheng M, Li Y, Li T, Zhang L, Zhou L. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: a SEER-based analysis. Cancer Med. 2019;8:5128–36. https://doi.org/10.1002/cam4.2431.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kamarajah SK, Markar SR, Phillips AW, Salti GI, Dahdaleh F, Griffiths EA. Palliative gastrectomy for metastatic gastric adenocarcinoma: a national population-based cohort study. Surgery. 2021;170:1702–10. https://doi.org/10.1016/j.surg.2021.07.016.

    Article  PubMed  Google Scholar 

  17. Granieri S, Altomare M, Bruno F, Paleino S, Bonomi A, Germini A, et al. Surgical treatment of gastric cancer liver metastases: systematic review and meta-analysis of long-term outcomes and prognostic factors. Crit Rev Oncol Hematol. 2021;163:103313. https://doi.org/10.1016/j.critrevonc.2021.103313.

    Article  PubMed  Google Scholar 

  18. Ikari N, Taniguchi K, Serizawa A, Yamada T, Yamamoto M, Furukawa T. A primary tumor of mixed histological type is a novel poor prognostic factor for patients undergoing resection of liver metastasis from gastric cancer. J Hepatobiliary Pancreat Sci. 2017;24:281–8. https://doi.org/10.1002/jhbp.445.

    Article  PubMed  Google Scholar 

  19. Yamaguchi T, Kashu N, Yasuda K, Yoshitake H, Takami T, Hatano K, et al. Two cases of advanced gastric cancer with simultaneous liver metastasis with long-term recurrence-free survival. Gan to Kagaku Ryoho Cancer Chemotherapy. 2019;46:2333–5 (PMID: 32156922).

    PubMed  Google Scholar 

  20. Ozato Y, Kawabata R, Furukawa H, Shinno N, Sueda T, Matsumura T, et al. A case of long-term survival without recurrence following resection of hepatic and pulmonary metastases of gastric cancer. Gan to Kagaku Ryoho Cancer Chemotherapy. 2019;46:580–2 (PMID: 30914620).

    PubMed  Google Scholar 

  21. Kawahara K, Makino H, Kametaka H, Hoshino I, Fukada T, Seike K, et al. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis. World J Surg Oncol. 2020;18:41. https://doi.org/10.1186/s12957-020-01816-9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Shirasu H, Tsushima T, Kawahira M, Kawai S, Kawakami T, Kito Y, et al. Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer. 2018;21:338–44. https://doi.org/10.1007/s10120-017-0730-9.

    Article  PubMed  Google Scholar 

  23. Li Y, Xie D, Chen X, Hu T, Lu S, Han Y. Prognostic value of the site of distant metastasis and surgical interventions in metastatic gastric cancer: a population-based study. Technol Cancer Res T. 2020;19:1533033820964131. https://doi.org/10.1177/1533033820964131.

    Article  CAS  Google Scholar 

  24. Jeong S-A, Yoo M-W, Lee I-S, Gong CS, Ko CS, Jheong JH, et al. Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: a retrospective study with propensity score matching. Eur J Surg Oncol. 2022;48:1988–93. https://doi.org/10.1016/j.ejso.2022.05.019.

    Article  PubMed  Google Scholar 

  25. Xie Y, Song X, Dong W, Jin H, Ni Z, Li X, et al. Anatomic subsites and prognosis of gastric signet ring cell carcinoma: a SEER population-based 1: 1 propensity-matched study. Biomed Res Int. 2022;2022:1565207. https://doi.org/10.1155/2022/1565207.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Dias AR, Pereira MA, Ramos MFKP, Barchi LC, Ribeiro U, Zilberstein B, et al. Gastrectomy for elderly gastric cancer patients: a propensity score-matching analysis. J Surg Oncol. 2022;126:108–15. https://doi.org/10.1002/jso.26850.

    Article  CAS  PubMed  Google Scholar 

  27. Pausch TM, Liu X, Cui J, Wei J, Miao Y, Heger U, et al. Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis. Cancers. 2021;14:57. https://doi.org/10.3390/cancers14010057.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy. Diagn Interv Radiol (Ankara, Turkey). 2019;25:360–7. https://doi.org/10.5152/dir.2019.18390.

    Article  Google Scholar 

  29. Yamaguchi H, Honda M, Hamada K, Kobayashi H, Todate Y, Seto I, et al. The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients. Jpn J Clin Oncol. 2020;50:903–8. https://doi.org/10.1093/jjco/hyaa052.

    Article  PubMed  Google Scholar 

  30. Akamaru Y, Wada N, Adachi S, Hokkoku D, Eguchi S, Wada R, et al. Two cases of liver metastasis from gastric cancer achieving long-term survival successfully treated with stereotactic body radiotherapy (SBRT). Gan to Kagaku Ryoho Cancer Chemotherapy. 2019;46:2110–2.

    PubMed  Google Scholar 

  31. Li K, Zhang A, Li X, Zhang H, Zhao L. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188615. https://doi.org/10.1016/j.bbcan.2021.188615.

    Article  CAS  PubMed  Google Scholar 

  32. Fujitani K, Kurokawa Y, Takeno A, Kawabata R, Omori T, Imamura H, et al. Prospective multicenter interventional study of surgical resection for liver metastasis from gastric cancer: R0 resection rate, and operative morbidity and mortality. Ann Surg Oncol. 2022;29:924–32. https://doi.org/10.1245/s10434-021-10750-3.

    Article  PubMed  Google Scholar 

  33. Shan B, Shan L, Morris D, Golani S, Saxena A. Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma. J Gastrointest Oncol. 2015;6:544–60. https://doi.org/10.3978/j.issn.2078-6891.2015.046.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Hainan Province's Key Research and Development Project (No. ZDYF2021SHFZ234), the Research Project of Hainan Provincial Health Commission (No. 22A200071), the Hainan Provincial Natural Science Foundation Youth Fund Funding Project (No. 819QN364), and the Funds of Talent Recruitment and Development of The Second Affiliated Hospital of Hainan Medical University.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study's conception and design. Material preparation, data collection, and analysis were performed by NNJ, WT, XWW, and RL. The first draft of the manuscript was written by NNJ. Statistical analysis: QC, ZHL and YCZ, and all authors commented on previous versions of the manuscript and approved the final manuscript.

Corresponding authors

Correspondence to Yue-Can Zeng or Zhi-Hui Li.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethical approval and informed consent

This study has been approved by the Ethics Committee of The Second Affiliated Hospital of Hainan Medical University. The access to and use of SEER data did not require informed patient consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ji, NN., Wu, XW., Cao, Q. et al. Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer. Clin Transl Oncol 26, 756–764 (2024). https://doi.org/10.1007/s12094-023-03305-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-023-03305-3

Keywords

Navigation